WO2010147697A2 - Curable fluoroelastomer compositions - Google Patents

Curable fluoroelastomer compositions Download PDF

Info

Publication number
WO2010147697A2
WO2010147697A2 PCT/US2010/030677 US2010030677W WO2010147697A2 WO 2010147697 A2 WO2010147697 A2 WO 2010147697A2 US 2010030677 W US2010030677 W US 2010030677W WO 2010147697 A2 WO2010147697 A2 WO 2010147697A2
Authority
WO
WIPO (PCT)
Prior art keywords
group
monomer
curable composition
cure site
copolymerized units
Prior art date
Application number
PCT/US2010/030677
Other languages
French (fr)
Other versions
WO2010147697A3 (en
Inventor
Ming-Hong Hung
Bruno Ameduri
Guillaume Tillet
Original Assignee
Dupont Performance Elastomers L.L.C.
Le Centre National De La Recherche Scientifique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Performance Elastomers L.L.C., Le Centre National De La Recherche Scientifique filed Critical Dupont Performance Elastomers L.L.C.
Priority to JP2012516082A priority Critical patent/JP5607730B2/en
Priority to CN201080027107.5A priority patent/CN102549065B/en
Priority to EP10789893.4A priority patent/EP2443193B1/en
Publication of WO2010147697A2 publication Critical patent/WO2010147697A2/en
Publication of WO2010147697A3 publication Critical patent/WO2010147697A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L27/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Compositions of derivatives of such polymers
    • C08L27/02—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L27/12—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Compositions of derivatives of such polymers not modified by chemical after-treatment containing fluorine atoms
    • C08L27/16—Homopolymers or copolymers or vinylidene fluoride
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2205/00—Polymer mixtures characterised by other features
    • C08L2205/02—Polymer mixtures characterised by other features containing two or more polymers of the same C08L -group
    • C08L2205/025—Polymer mixtures characterised by other features containing two or more polymers of the same C08L -group containing two or more polymers of the same hierarchy C08L, and differing only in parameters such as density, comonomer content, molecular weight, structure

Definitions

  • This invention relates to curable fluoroelastomer compositions comprising fluoroelastomers having either nitrile, alkyne or azide cure sites and fluorinated curatives containing diazide, dinitrile or dialkyne groups for reacting with cure sites on the fluoroelastomer.
  • Elastomeric fluoropolymers exhibit excellent resistance to the effects of heat, weather, oil, solvents and chemicals.
  • Such materials are commercially available and are most commonly either copolymers of vinylidene fluoride (VF2) with hexafluoropropylene (HFP) or copolymers of VF 2 , HFP, and tetrafluoroethylene (TFE).
  • VF2 vinylidene fluoride
  • HFP hexafluoropropylene
  • TFE tetrafluoroethylene
  • fluoroelastomers include the copolymers of TFE with one or more hydrocarbon olefins such as ethylene (E) or propylene (P), and also the copolymers of TFE with a perfluoro(alkyl vinyl ether) such as perfluoro(methyl vinyl ether) (PMVE).
  • hydrocarbon olefins such as ethylene (E) or propylene (P)
  • PMVE perfluoro(methyl vinyl ether)
  • fluoroelastomers require incorporation of a cure site monomer into their polymer chains in order to crosslink efficiently (Logothetis, A.L., Prog. Polym. ScL, Vol. 14, pp 251-296 (1989); A. Taguet et al. Advances in Polymer Science, Vol. 184, pp 127-211 (2005)). Without such a cure site monomer, the fluoroelastomer may not react at all with curing agents, it may only partially react, or reaction may be too slow for use on a commercial scale. Seals made from poorly crosslinked elastomers often fail sooner than might otherwise be expected. Unfortunately, disadvantages are associated with many of the cure site monomers and curatives in use today. For example, some curatives are toxic.
  • Cure site monomers which contain reactive bromine or iodine atoms can release byproducts during the curing reaction that are harmful to the environment.
  • Other cure site monomers e.g. those which contain double bonds at both ends of the molecule
  • incorporation of a cure site monomer into a fluoroelastomer polymer chain may negatively impact the properties of the fluoroelastomer (both physical properties and chemical resistance).
  • An aspect of the present invention is a curable composition
  • a curable composition comprising
  • A) a fluoroelastomer comprising copolymerized units of i) a first monomer selected from the group consisting of vinylidene fluoride and tetrafluoroethylene and ii) a cure site monomer having a cure site selected from the group consisting of azide, sulfonyl azide and carbonyl azide groups; and
  • X is an alkyne group or a nitrile group
  • n, m are independently 1 to 4
  • R is selected from the group consisting of i) a C 3 - C 10 fluoroalkylene group, ii) a C 3 - C 10 fluoroalkoxylene group, iii) a substituted arylene group, iv) an oligomer comprising copolymerized units of vinylidene fluoride and perfluoro(methyl vinyl ether), v) an oligomer comprising copolymerized units of vinylidene fluoride and hexafluoropropylene, vi) an oligomer comprising copolymerized units of tetrafluoroethylene and perfluoro(methyl vinyl ether), and vii) an oligomer comprising copolymerized units of tetrafluor
  • A) a fluoroelastomer comprising copolymerized units of i) a first monomer selected from the group consisting of vinylidene fluoride and tetrafluoroethylene and ii) a cure site monomer having a cure site selected from the group consisting of nitrile groups, and alkyne groups; and
  • the present invention is directed to curable fluoroelastomer compositions that are based on new combinations of copolymerized cure site monomers and curing agents.
  • Fluoroelastomers employed in the curable compositions of the invention typically contain between 25 and 70 weight percent, based on the total weight of the fluoroelastomer, of copolymerized units of a first monomer which may be vinylidene fluoride (VF 2 ), or tetrafluoroethylene (TFE).
  • the fluoroelastomer further comprises 0.2 to 10 (preferably 0.1 to 5) weight percent, based on the total composition of the fluoroelastomer, of copolymerized units of a cure site monomer (hereinafter defined).
  • the remaining units in the fluoroelastomers are comprised of at least one additional copolymerized monomer, different from both said first monomer and said cure site monomer, said additional copolymerized monomer selected from the group consisting of fluoromonomers, hydrocarbon olefins and mixtures thereof.
  • Fluoromonomers include both fluorine- containing olefins (fluoroolefins) and fluorine-containing vinyl ethers (fluorovinyl ethers).
  • Fluorine-containing olefins which may be employed in the fluoroelastomers include, but are not limited to vinylidene fluoride (VF 2 ), hexafluoropropylene (HFP), tetrafluoroethylene (TFE), 1 ,2,3,3,3- pentafluoropropene (1-HPFP), 1 ,1 ,3,3,3-pentafluoropropene (2-HPFP), 3,3,3-trifluoropropene; chlorotrifluoroethylene (CTFE) and vinyl fluoride.
  • VF 2 vinylidene fluoride
  • HFP hexafluoropropylene
  • TFE tetrafluoroethylene
  • 1-HPFP 1,2,3,3,3- pentafluoropropene
  • 2-HPFP 1,1 ,3,3,3-pentafluoropropene
  • CFE chlorotrifluoroethylene
  • vinyl fluoride VF 2
  • HFP hexa
  • Fluorine-containing vinyl ethers that may be employed in the fluoroelastomers include, but are not limited to perfluoro(alkyl vinyl) ethers and partially fluorinated vinyl ethers.
  • Perfluoro(alkyl vinyl) ethers (PAVE) suitable for use as monomers include those of the formula
  • CF 2 CFO(R, O) n (RrO) 1n R, (I) where R f and R r are different linear or branched perfluoroalkylene groups of 2-6 carbon atoms, m and n are independently 0-10, and R f is a perfluoroalkyl group of 1-6 carbon atoms.
  • a preferred class of perfluoro(alkyl vinyl) ethers includes compositions of the formula
  • CF 2 CFO(CF 2 CFXO) n Rf (II) where X is F or CF3, n is 0-5, and Rf is a perfluoroalkyl group of 1-6 carbon atoms.
  • a most preferred class of perfluoro(alkyl vinyl) ethers includes those ethers wherein n is 0 or 1 and R f contains 1-3 carbon atoms.
  • Examples of such perfluorinated ethers include perfluoro(methyl vinyl) ether (PMVE) 1 perfluoro(ethyl vinyl ether) (PEVE) and perfluoro(propyl vinyl) ether (PPVE).
  • Other useful monomers include compounds of the formula
  • Additional perfluoro(alkyl vinyl) ether monomers include compounds of the formula
  • CF2 CFO[(CF2CF ⁇ CF3 ⁇ O) n (CF2CF2CF2 ⁇ ) m (CF2)p]C ⁇ F 2x+ i (IV)
  • Other examples of useful perfluoro(alkyl vinyl ethers) include
  • the PAVE content generally ranges from 25 to 65 weight percent, based on the total weight of the fluoroelastomer. If perfluoro(methyl vinyl) ether is used, then the fluoroelastomer preferably contains between 30 and 65 wt.% copolymerized PMVE units.
  • Hydrocarbon olefins useful in the fluoroelastomers employed in this invention include, but are not limited to ethylene (E) and propylene (P). If copolymerized units of a hydrocarbon olefin are present in the fluoroelastomers, hydrocarbon olefin content is generally 4 to 30 weight percent.
  • fluoroelastomers that may be employed in this invention (cure site monomers omitted for clarity) include, but are not limited to copolymerized units of TFE/PMVE, VF 2 /PMVE, VF 2 /TFE/PMVE,
  • TFE/PMVE/E JFE/P
  • TFE/P/VF 2 TFE/PMVE/E, JFE/P and TFE/P/VF 2 .
  • Cure site monomers that may be employed in the fluoroelastomers are those having nitrile, alkyne or azide groups which will serve as reactive sites to form crosslinks with a curing agent.
  • Useful nitrile-containing cure site monomers include those of the formulas shown below.
  • Those of formula (VIII) are preferred.
  • Especially preferred cure site monomers are perfluorinated polyethers having a nitrile group and a trifluorovinyl ether group. A most preferred cure site monomer is
  • Cure site monomers that contain azide groups include those containing sulfonyl azide or carbonyl azide groups.
  • CF 2 CFOCF 2 CF(CF 3 )OCF 2 CF 2 -CON 3
  • the latter may be synthesized by the following reactions starting from CICF 2 -CFCI-O-CF 2 CF(CF 3 )-OCF 2 CF 2 -COOH (hereinafter CI 2 -EVE-COOH).
  • EVE-C ⁇ CH EVE-C ⁇ CH
  • Fluoroelastomers employed in the invention may be made by a solution, suspension or emulsion polymerization process. Such processes are well known in the art.
  • an emulsion process is employed wherein an inorganic peroxide (e.g. sodium or ammonium persulfate) is the initiator.
  • an inorganic peroxide e.g. sodium or ammonium persulfate
  • a surfactant particularly a fluorosurfactant may be included in order to improve the stability of the emulsion.
  • the curatives that may be employed in the compositions of the invention are those of formula X-(CH2) n -R-(CH2) m -X, wherein X is an alkyne group or a nitrile group, n and m are independently 1 to 4, and R is selected from the group consisting of i) a C3 - C10 fluoroalkylene group, ii) a C3 - C 1 0 fluoroalkoxylene group, iii) a substituted arylene group, iv) an oligomer comprising copolymerized units of vinylidene fluoride and perfluoro(methyl vinyl ether), v) an oligomer comprising copolymerized units of vinylidene fluoride and hexafluoropropylene, vi) an oligomer comprising copolymerized units of tetrafluoroethylene and perflu
  • Hydrocarbon olefins that may be employed include ethylene and propylene. These oligomers (i.e. low molecular weight copolymers) may be prepared according to the processes disclosed in U.S. 20090105435 A1. Such oligomers preferably contain 10 to 50 mole percent perfluoro(methyl vinyl ether). The oligomers have a number average molecular weight of 1000 to 25,000, preferably 1200 to 12,000, most preferably 1500 to 5000.
  • the curatives that may be employed in the compositions of the invention are those of formula N 3 (Y) p -(CH 2 ) n -R- (CH 2 ) m -(Y)pN 3 , wherein Y is SO 1 SO 2 , C 6 H 4 , or CO, p is 0 or 1 , n and m are independently 1 to 4, and R is selected from the group consisting of i) a C 3 - C 10 fluoroalkylene group, ii) a C 3 - C 10 fluoroalkoxylene group, iii) a substituted arylene group, iv) an oligomer comprising copolymerized units of vinylidene fluoride and perfluoro(methyl vinyl ether), v) an oligomer comprising copolymerized units of vinylidene fluoride and hexafluoroprop
  • curing agents include, but are not limited to N 3 CH 2 CH 2 CF 2 CF 2 CF 2 CF 2 CF 2 CF 2 CH 2 CH 2 N 3 ; N 3 -CH 2 CH 2 - (CFz) 4 -CH 2 CH 2 N 3 (U.S. Patent 4,020,176); N 3 -CO-CH 2 -(CF 2 VCH 2 -CO- N 3 (JP 57108055 A); and N 3 C 2 H 4 -PoIy(VF 2 -CO-PMVE)-C 2 H 4 N 3 .
  • the latter may be prepared by the reaction of sodium azide with 1-CH 2 CH 2 -(VF 2 -Co- PMVE)-CH 2 CH 2 -I made according to the process of US 20090105435 A1.
  • Curable compositions of the invention may also, optionally, contain additives typically employed in the elastomer industry including, but not ' limited to accelerators, acid acceptors, fillers, colorants, process aids, etc.
  • compositions and the structures were determined by 19 F and 1 H NMR spectroscopy.
  • the NMR spectra were recorded on BRUKER® AC 250 or 400 (250 and 400 MHz) instruments, using deuterated acetone as the solvent and tetramethylsilane (TMS) or CFCI 3 as the references for 1 H (or 19 F) nuclei. Coupling constants and chemical shifts are given in Hz and ppm, respectively.
  • SEC Size Exclusion Chromatography analysis was performed with a Spectra-Physics apparatus equipped with two PLgel 5 ⁇ m Mixed-C columns from Polymer Laboratories and a Spectra Physics SP8430 Rl detector. Tetrahydrofuran (THF) was the eluent, temperature was 30 0 C, and the flow rate was 0.8 ml_ min '1 . Poly(styrene) or poly(methylmethacrylate) standards (Polymer Laboratories) were used to give relative values of the molecular weights. Samples of a known concentration (ca. 2 wt.%) were filtered through a 200 micron PTFE chromafil membrane prior to injection.
  • THF Tetrahydrofuran
  • Poly(styrene) or poly(methylmethacrylate) standards Polymer Laboratories
  • T 9 The glass transition temperatures (T 9 ) were determined by differential scanning calorimetry (DSC) using a Perkin Elmer Pyris 1 apparatus calibrated with indium and n-decane. The samples (about 10 mg) were initially cooled to -105 °C for 10 mins, then heated from -100° to 50 0 C at a heating rate of 20 0 C /min (a second recooling was done to -105 0 C, and the same cycle repeated three times). The values of T 9 reported herein correspond to the inflection point of the differential heat flow.
  • TGA analyses were performed using a Texas Instrument ATG 51- 133 apparatus under air at the heating rate of 20°C/min from room temperature (approximately 20 0 C) up to 550°C.
  • a curable composition of the invention comprising a) a fluoroelastomer terpolymer of vinylidene fluoride (VF 2 ), perfluoro(methyl vinyl ether) (PMVE) and
  • Hastelloy autoclave equipped with inlet and outlet valves, a manometer and a rupture disc, was degassed and pressurized with 30 bar of nitrogen to check for leaks. Then, a 0.5 mm Hg vacuum was operated for 5 minutes (min.) and subsequently an Ar atmosphere was applied. This autoclave degassing procedure was repeated five times.
  • the autoclave was progressively heated to 8O 0 C. During the reaction, the pressure dropped from 22 to 14 bars in 24 hours. After reaction, the autoclave was placed in an ice bath for about 60 minutes and 25 g of unreacted PMVE and VF 2 was slowly released. The conversion of gases was 38 %. After opening the autoclave, 150 ml of butanone was added and the organic layer was separated in a separating funnel, was dried over MgSCU and filtered through sintered glass (G4). The organic solvent was removed by a rotating vacuum evaporator at (40°C/20 mm Hg). The resulting yellow viscous liquid was dried at 4O 0 C and 0.01 mbar vacuum to constant weight. The product (yield 56 %) was analyzed by 1 H and 19 F NMR spectroscopy.
  • the batch bismonoaddition of ⁇ , ⁇ -diiodoperfluorohexane onto ethylene was performed in a 160 ml_ Hastelloy autoclave Parr System, equipped with a manometer, a rupture disk, inlet and outlet valves, and a mechanical anchor.
  • An electronic device regulated and controlled both the stirring and the heating of the autoclave.
  • the autoclave was left closed for 20 min. and purged with 30 bars of nitrogen pressure to prevent any leakage, and degassed afterwards. Then, a 2 mm Hg vacuum was operated for 15 min.
  • the initiator di-4-tert-butylcyclohexyl peroxydicarbonate (4.22 g, 10 mmol) and 30.13 g (54.2 mmol) of 1-C 6 Fi 2 -I in dry tert-butanol (40 ml_) were introduced via a funnel tightly connected to the introduction valve.
  • ethylene 4.0 g, 0.14 mol
  • the autoclave was then heated up to 5O 0 C for 7 hours. After reaction, the autoclave was cooled to room temperature and then put into an ice bath. After degassing the unreacted monomer, the autoclave was opened.
  • a curable composition of the invention is made by dissolving 5 g of the above-prepared VF 2 /PMVE/8-CNVE fluoroelastomer in FC-75 solvent (available from 3M) and then mixed with 0.4 g of the telechelic 1 ,10- diazido-1H,1 H,2H,2H,9H,9H,10H,10H-perfluorodecane curing agent prepared above.
  • This curable composition is mixed until a clear, transparent and homogenous solution is obtained.
  • the curable composition is then cast into a mold, resulting in a film.
  • the film is cured at 150 0 C for 14 to 20 hours.
  • a curable composition of the invention was made by dissolving 5 g of a TFE/PMVE/8-CNVE fluoroelastomer (prepared substantially as disclosed in US Patent No. 5,789,489 and containing about 64-67 mol% TFE, 32-34 mol% PMVE and 0.7-1.2 mol% 8-CNVE) in FC-75 solvent (available from 3M) and then mixed with 0.4 g of the telechelic 1 ,10- diazido-I H.I H ⁇ H ⁇ H. ⁇ H. ⁇ H.IOH.IOH-perfluorodecane curing agent prepared above, and 0.5 g of zinc chloride. This curable composition was mixed until a clear, transparent and homogenous solution was obtained.
  • the curable composition was then cast into a mold, resulting in a film.
  • the film was cured at 150 0 C for 14 to 20 hours.
  • the resulting crosslinked fluoroelastomer composition was insoluble in FC-75, whereas the uncured composition had been soluble in FC-75.
  • TGA showed that T10% was 442°C, while it was 424 0 C for uncured fluoroelastomer.
  • a crosslinking mechanism is shown below wherein azide groups on the curative react with pendant nitrile groups on the fluoroelastomer to form crosslinks through tetrazole rings.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

This invention relates to curable fluoroelastomer compositions comprising a) fluoroelastomers having either nitrile, alkyne or azide cure sites and b) fluorinated curatives containing diazide, dinitrile or dialkyne groups for reacting with cure sites on the fluoroelastomer. Fluoroelastomers having azide cure sites form crosslinks with curatives having dinitrile or dialkyne groups. Fluoroelastomers having nitrile or alkyne cure sites form crosslinks with curatives having diazide groups.

Description

TITLE OF THE INVENTION
CURABLE FLUOROELASTOMER COMPOSITIONS
FIELD OF THE INVENTION
This invention relates to curable fluoroelastomer compositions comprising fluoroelastomers having either nitrile, alkyne or azide cure sites and fluorinated curatives containing diazide, dinitrile or dialkyne groups for reacting with cure sites on the fluoroelastomer.
BACKGROUND OF THE INVENTION
Elastomeric fluoropolymers (i.e. fluoroelastomers) exhibit excellent resistance to the effects of heat, weather, oil, solvents and chemicals. Such materials are commercially available and are most commonly either copolymers of vinylidene fluoride (VF2) with hexafluoropropylene (HFP) or copolymers of VF2, HFP, and tetrafluoroethylene (TFE).
Other common fluoroelastomers include the copolymers of TFE with one or more hydrocarbon olefins such as ethylene (E) or propylene (P), and also the copolymers of TFE with a perfluoro(alkyl vinyl ether) such as perfluoro(methyl vinyl ether) (PMVE).
Many fluoroelastomers require incorporation of a cure site monomer into their polymer chains in order to crosslink efficiently (Logothetis, A.L., Prog. Polym. ScL, Vol. 14, pp 251-296 (1989); A. Taguet et al. Advances in Polymer Science, Vol. 184, pp 127-211 (2005)). Without such a cure site monomer, the fluoroelastomer may not react at all with curing agents, it may only partially react, or reaction may be too slow for use on a commercial scale. Seals made from poorly crosslinked elastomers often fail sooner than might otherwise be expected. Unfortunately, disadvantages are associated with many of the cure site monomers and curatives in use today. For example, some curatives are toxic. Cure site monomers which contain reactive bromine or iodine atoms can release byproducts during the curing reaction that are harmful to the environment. Other cure site monomers (e.g. those which contain double bonds at both ends of the molecule) may be so reactive that they disrupt polymerization of the fluoroelastomer by altering the polymerization rate, terminating polymerization, or by causing undesirable chain branching, or even gelation to occur. Lastly, incorporation of a cure site monomer into a fluoroelastomer polymer chain may negatively impact the properties of the fluoroelastomer (both physical properties and chemical resistance).
There exists a need in the art for new fluoroelastomer cure systems, both new cure site monomers which are environmentally friendly, do not disrupt polymerization and which do not detract from the properties of the fluoroelastomer, and new curatives for forming crosslinks with cure site monomers.
SUMMARY OF THE INVENTION
An aspect of the present invention is a curable composition comprising
A) a fluoroelastomer comprising copolymerized units of i) a first monomer selected from the group consisting of vinylidene fluoride and tetrafluoroethylene and ii) a cure site monomer having a cure site selected from the group consisting of azide, sulfonyl azide and carbonyl azide groups; and
B) a curative having the formula X-(CH2)π-R-(CH2)m-X. wherein X is an alkyne group or a nitrile group, n, m are independently 1 to 4, and R is selected from the group consisting of i) a C3 - C10 fluoroalkylene group, ii) a C3 - C10 fluoroalkoxylene group, iii) a substituted arylene group, iv) an oligomer comprising copolymerized units of vinylidene fluoride and perfluoro(methyl vinyl ether), v) an oligomer comprising copolymerized units of vinylidene fluoride and hexafluoropropylene, vi) an oligomer comprising copolymerized units of tetrafluoroethylene and perfluoro(methyl vinyl ether), and vii) an oligomer comprising copolymerized units of tetrafluoroethylene and a hydrocarbon olefin. Another aspect of the present invention is a curable composition comprising
A) a fluoroelastomer comprising copolymerized units of i) a first monomer selected from the group consisting of vinylidene fluoride and tetrafluoroethylene and ii) a cure site monomer having a cure site selected from the group consisting of nitrile groups, and alkyne groups; and
B) a curative having the formula N3(Y)p-(CH2)n-R-(CH2)m-(Y)pN3, wherein Y is SO, SO2, CeH4, or CO, p is 0 or 1 , n, m are independently 1 to 4, and R is selected from the group consisting of i) a C3 - C10 fluoroalkylene group, ii) a C3 - Ci0 fluoroalkoxylene group, iii) a substituted arylene group, iv) an oligomer comprising copolymerized units of vinylidene fluoride and perfluoro(methyl vinyl ether), v) an oligomer comprising copolymerized units of vinylidene fluoride and hexafluoropropylene, vi) an oligomer comprising copolymerized units of tetrafluoroethylene and perfluoro(methyl vinyl ether), and vii) an oligomer comprising copolymerized units of tetrafluoroethylene and a hydrocarbon olefin
DETAILED DESCRIPTION OF THE INVENTION
The present invention is directed to curable fluoroelastomer compositions that are based on new combinations of copolymerized cure site monomers and curing agents.
Fluoroelastomers employed in the curable compositions of the invention typically contain between 25 and 70 weight percent, based on the total weight of the fluoroelastomer, of copolymerized units of a first monomer which may be vinylidene fluoride (VF2), or tetrafluoroethylene (TFE). The fluoroelastomer further comprises 0.2 to 10 (preferably 0.1 to 5) weight percent, based on the total composition of the fluoroelastomer, of copolymerized units of a cure site monomer (hereinafter defined). The remaining units in the fluoroelastomers are comprised of at least one additional copolymerized monomer, different from both said first monomer and said cure site monomer, said additional copolymerized monomer selected from the group consisting of fluoromonomers, hydrocarbon olefins and mixtures thereof. Fluoromonomers include both fluorine- containing olefins (fluoroolefins) and fluorine-containing vinyl ethers (fluorovinyl ethers).
Fluorine-containing olefins which may be employed in the fluoroelastomers include, but are not limited to vinylidene fluoride (VF2), hexafluoropropylene (HFP), tetrafluoroethylene (TFE), 1 ,2,3,3,3- pentafluoropropene (1-HPFP), 1 ,1 ,3,3,3-pentafluoropropene (2-HPFP), 3,3,3-trifluoropropene; chlorotrifluoroethylene (CTFE) and vinyl fluoride.
Fluorine-containing vinyl ethers that may be employed in the fluoroelastomers include, but are not limited to perfluoro(alkyl vinyl) ethers and partially fluorinated vinyl ethers. Perfluoro(alkyl vinyl) ethers (PAVE) suitable for use as monomers include those of the formula
CF2=CFO(R, O)n(RrO)1nR, (I) where Rf and Rr are different linear or branched perfluoroalkylene groups of 2-6 carbon atoms, m and n are independently 0-10, and Rf is a perfluoroalkyl group of 1-6 carbon atoms.
A preferred class of perfluoro(alkyl vinyl) ethers includes compositions of the formula
CF2=CFO(CF2CFXO)nRf (II) where X is F or CF3, n is 0-5, and Rf is a perfluoroalkyl group of 1-6 carbon atoms.
A most preferred class of perfluoro(alkyl vinyl) ethers includes those ethers wherein n is 0 or 1 and Rf contains 1-3 carbon atoms. Examples of such perfluorinated ethers include perfluoro(methyl vinyl) ether (PMVE)1 perfluoro(ethyl vinyl ether) (PEVE) and perfluoro(propyl vinyl) ether (PPVE). Other useful monomers include compounds of the formula
CF2=CFO[(CF2)mCF2CFZO]nRf (III) where Rf is a perfluoroalkyl group having 1-6 carbon atoms, m = 0 or 1 , n = 0-5, and Z = F or CF3. Preferred members of this class are those in which Rf is C3F7, m = 0, and n = 1.
Additional perfluoro(alkyl vinyl) ether monomers include compounds of the formula
CF2=CFO[(CF2CF{CF3}O)n(CF2CF2CF2θ)m(CF2)p]CχF2x+i (IV) where m and n independently = 0-10, p = 0-3, and x = 1-5. Preferred members of this class include compounds where n = 0-1 , m = 0-1 , and x = 1. Other examples of useful perfluoro(alkyl vinyl ethers) include
CF2=CFOCF2CF(CF3)O(CF2O)mCnF2n+1 (V) where n = 1-5, m = 1-3, and where, preferably, n = 1.
If copolymerized units of PAVE are present in the fluoroelastomers employed in the invention, the PAVE content generally ranges from 25 to 65 weight percent, based on the total weight of the fluoroelastomer. If perfluoro(methyl vinyl) ether is used, then the fluoroelastomer preferably contains between 30 and 65 wt.% copolymerized PMVE units.
Hydrocarbon olefins useful in the fluoroelastomers employed in this invention include, but are not limited to ethylene (E) and propylene (P). If copolymerized units of a hydrocarbon olefin are present in the fluoroelastomers, hydrocarbon olefin content is generally 4 to 30 weight percent.
Specific examples of fluoroelastomers that may be employed in this invention (cure site monomers omitted for clarity) include, but are not limited to copolymerized units of TFE/PMVE, VF2/PMVE, VF2/TFE/PMVE,
TFE/PMVE/E, JFE/P and TFE/P/VF2.
Cure site monomers that may be employed in the fluoroelastomers are those having nitrile, alkyne or azide groups which will serve as reactive sites to form crosslinks with a curing agent. Useful nitrile-containing cure site monomers include those of the formulas shown below.
CF2=CF-O(CF2)n-CN (Vl) where n = 2-12, preferably 2-6;
CF2=CF-O[CF2-CF(CF3)-O]n-CF2-CF(CF3)-CN (VII) where n= 0-4, preferably 0-2;
CF2=CF-[OCF2CF(CF3)]x-O-(CF2)n-CN (VIII) where x = 1-2, and n = 1-4; and CF2=CF-O-(CFz)n-O-CF(CF3)CN (IX) where n = 2-4. Those of formula (VIII) are preferred. Especially preferred cure site monomers are perfluorinated polyethers having a nitrile group and a trifluorovinyl ether group. A most preferred cure site monomer is
CF2=CFOCF2CF(CF3)OCF2CF2CN (X) Cure site monomers that contain azide groups include those containing sulfonyl azide or carbonyl azide groups. Examples of sulfonyl azide cure site monomers include, but are not limited to CF2=CFOCF2CF(CF3)OCF2CF2-SO2N3; CF2=CFOCF2CF2-SO2N3; CF2=CFOCF2CF2CF2-SO2N3; and CF2=CFOCF2CF2CF2CF2-SO2N3 as disclosed in U.S. Patent 6,365,693 B1. An example of a carbonyl azide cures site monomer is CF2=CFOCF2CF(CF3)OCF2CF2-CON3 (hereinafter EVE- CON3). The latter may be synthesized by the following reactions starting from CICF2-CFCI-O-CF2CF(CF3)-OCF2CF2-COOH (hereinafter CI2-EVE-COOH).
CI2-EVE-COOH + PCI5 -— » CI2-EVE-COCI
CI2-EVE-COCI + HN3/Pyridine (or NaN3) — > CI2-EVE-CON3
CI2-EVE-CON3 + Zn — -» EVE-CON3 + ZnCI2
Examples of cure site monomers that contain alkyne groups include, but are not limited to CF2=CFOCF2CF(CF3)OCF2CF2-C=CH; CF2=CFOCF2CF(CF3)OCF2CF2-COOCH2C=CH; and CF2=CFOCF2CF(CF3)QCF2CF2-CH2CH2-O-CH2C=CH. A synthesis for CF2=CFOCF2CF(CF3)OCF2CF2-C=CH (hereinafter EVE-C≡CH) from Cl2- EVE-COOH is below.
CI2-EVE-COOH + PCI5 — -» CI2-EVE-COCI CI2-EVE-COCI + Kl/Hβat — - » CI2-EVE-I CI2-EVE-I + CH2=CH2 — - » CI2-EVE-CH2CH2-I CI2-EVE-CH2CH2-I + KOH — -> CI2-EVE-CH=CH2 CI2-EVE-CH=CH2 + Br2 — - » CI2-EVE-CHBr-CH2Br CI2-EVE-CHBr-CH2Br + KOH -— » CI2-EVE-C=CH CI2-EVE-C=CH + Zn — -> EVE-C=CH + ZnCI2
Likewise CF2=CFOCF2CF(CF3)OCF2CF2-COOCH2C=CH (hereinafter EVE- COOCH2C=CH) may be synthesized via
CI2-EVE-COCI + HOCH2C=CH -» CI2-EVE- COOCH2C=CH + Zn ^
EVE-COOCH2C=CH
CF2=CFOCF2CF(CF3)OCF2CF2-CH2CH2-O-CH2C=CH (hereinafter EVE- CH2CH2-O-CH2C≡CH) may be synthesized via
CI2-EVE-CH2CH2-I + HOCH2C=CH + Base ^ CI2-EVE-CH2CH2-O- CH2C=CH + Zn -> EVE-CH2CH2-O-CH2C=CH
Fluoroelastomers employed in the invention may be made by a solution, suspension or emulsion polymerization process. Such processes are well known in the art. Preferably, an emulsion process is employed wherein an inorganic peroxide (e.g. sodium or ammonium persulfate) is the initiator. Optionally a surfactant, particularly a fluorosurfactant may be included in order to improve the stability of the emulsion. When the fluoroelastomer contains a cure site monomer having azide groups, the curatives that may be employed in the compositions of the invention are those of formula X-(CH2)n-R-(CH2)m-X, wherein X is an alkyne group or a nitrile group, n and m are independently 1 to 4, and R is selected from the group consisting of i) a C3 - C10 fluoroalkylene group, ii) a C3 - C10 fluoroalkoxylene group, iii) a substituted arylene group, iv) an oligomer comprising copolymerized units of vinylidene fluoride and perfluoro(methyl vinyl ether), v) an oligomer comprising copolymerized units of vinylidene fluoride and hexafluoropropylene, vi) an oligomer comprising copolymerized units of tetrafluoroethylene and perfluoro(methyl vinyl ether), and vii) an oligomer comprising copolymerized units of tetrafluoroethylene and a hydrocarbon olefin. Hydrocarbon olefins that may be employed include ethylene and propylene. These oligomers (i.e. low molecular weight copolymers) may be prepared according to the processes disclosed in U.S. 20090105435 A1. Such oligomers preferably contain 10 to 50 mole percent perfluoro(methyl vinyl ether). The oligomers have a number average molecular weight of 1000 to 25,000, preferably 1200 to 12,000, most preferably 1500 to 5000.
Specific examples of such curing agents include, but are not limited to NC-(CF2)n-CN (n = 2-20), see US 2,515,246 and Journal of Industrial and Engineering Chemistry (Washington, D. C.) (1947), 39, 415-17; and H C≡C-(CF2)n-C =CH (n = 2-20), see K. Baum, et al., J. Org. Chem., 47, 2251 (1982).
When the fluoroelastomer contains a cure site monomer having nitrile or alkyne groups, the curatives that may be employed in the compositions of the invention are those of formula N3(Y)p-(CH2)n-R- (CH2)m-(Y)pN3, wherein Y is SO1 SO2, C6H4, or CO, p is 0 or 1 , n and m are independently 1 to 4, and R is selected from the group consisting of i) a C3 - C10 fluoroalkylene group, ii) a C3 - C10 fluoroalkoxylene group, iii) a substituted arylene group, iv) an oligomer comprising copolymerized units of vinylidene fluoride and perfluoro(methyl vinyl ether), v) an oligomer comprising copolymerized units of vinylidene fluoride and hexafluoropropylene, vi) an oligomer comprising copolymerized units of tetrafluoroethylene and perfluoro(methyl vinyl ether), and vii) an oligomer comprising copolymerized units of tetrafluoroethylene and a hydrocarbon olefin.
Specific examples of such curing agents include, but are not limited to N3CH2CH2CF2CF2CF2CF2CF2CF2CH2CH2N3; N3-CH2CH2 - (CFz)4-CH2CH2 N3 (U.S. Patent 4,020,176); N3-CO-CH2-(CF2VCH2-CO- N3 (JP 57108055 A); and N3C2H4-PoIy(VF2-CO-PMVE)-C2H4N3. The latter may be prepared by the reaction of sodium azide with 1-CH2CH2-(VF2-Co- PMVE)-CH2CH2-I made according to the process of US 20090105435 A1.
Curable compositions of the invention may also, optionally, contain additives typically employed in the elastomer industry including, but not ' limited to accelerators, acid acceptors, fillers, colorants, process aids, etc.
EXAMPLES
TEST METHODS
Nuclear Magnetic Resonance Spectroscopy:
Compositions and the structures were determined by 19F and 1H NMR spectroscopy. The NMR spectra were recorded on BRUKER® AC 250 or 400 (250 and 400 MHz) instruments, using deuterated acetone as the solvent and tetramethylsilane (TMS) or CFCI3 as the references for 1H (or 19F) nuclei. Coupling constants and chemical shifts are given in Hz and ppm, respectively. The experimental conditions for 1H (or 19F) NMR spectra were the following: flip angle 90° (or 30°), acquisition time 4.5 s (or 0.7 s) , pulse delay 2 s (or 5 s) , number of scans 128 (or 512), and a pulse width of 5 μs for 19F NMR. Chromatography:
Size Exclusion Chromatography (SEC) analysis was performed with a Spectra-Physics apparatus equipped with two PLgel 5μm Mixed-C columns from Polymer Laboratories and a Spectra Physics SP8430 Rl detector. Tetrahydrofuran (THF) was the eluent, temperature was 300C, and the flow rate was 0.8 ml_ min'1. Poly(styrene) or poly(methylmethacrylate) standards (Polymer Laboratories) were used to give relative values of the molecular weights. Samples of a known concentration (ca. 2 wt.%) were filtered through a 200 micron PTFE chromafil membrane prior to injection.
Thermal Properties: The glass transition temperatures (T9) were determined by differential scanning calorimetry (DSC) using a Perkin Elmer Pyris 1 apparatus calibrated with indium and n-decane. The samples (about 10 mg) were initially cooled to -105 °C for 10 mins, then heated from -100° to 500C at a heating rate of 200C /min (a second recooling was done to -1050C, and the same cycle repeated three times). The values of T9 reported herein correspond to the inflection point of the differential heat flow.
TGA analyses were performed using a Texas Instrument ATG 51- 133 apparatus under air at the heating rate of 20°C/min from room temperature (approximately 200C) up to 550°C.
Example 1
In this example, a curable composition of the invention is made comprising a) a fluoroelastomer terpolymer of vinylidene fluoride (VF2), perfluoro(methyl vinyl ether) (PMVE) and
CF2=CFOCF2CF(CF3)OCF2CF2CN (8-CNVE) and b) a diazido curative. The resulting composition is then cured. (A) Synthesis of the fluoroelastomer:
A 300-mL Hastelloy autoclave, equipped with inlet and outlet valves, a manometer and a rupture disc, was degassed and pressurized with 30 bar of nitrogen to check for leaks. Then, a 0.5 mm Hg vacuum was operated for 5 minutes (min.) and subsequently an Ar atmosphere was applied. This autoclave degassing procedure was repeated five times. Under vacuum, 8.1 g (17.8 mmol) of 1 ,4-diiodoperfluorobutane, 0.3 g (1.26 mmol) of Na2S2O8 dissolved in 90 ml of water, 7.8 g (20 mmoi) of 8-CNVE and 1.35 g of ammonium perfluorooctanoate (3.13 mmol) dissolved in 5 ml of 1 ,1 ,1 ,3,3-pentafluorobutane were transferred into the autoclave. Then, by double weighing, 16 g (0.25 moles) of VF2 and 24 g (0.145 mol) of PMVE were introduced into the autoclave. Then, the autoclave was progressively heated to 8O0C. During the reaction, the pressure dropped from 22 to 14 bars in 24 hours. After reaction, the autoclave was placed in an ice bath for about 60 minutes and 25 g of unreacted PMVE and VF2 was slowly released. The conversion of gases was 38 %. After opening the autoclave, 150 ml of butanone was added and the organic layer was separated in a separating funnel, was dried over MgSCU and filtered through sintered glass (G4). The organic solvent was removed by a rotating vacuum evaporator at (40°C/20 mm Hg). The resulting yellow viscous liquid was dried at 4O0C and 0.01 mbar vacuum to constant weight. The product (yield 56 %) was analyzed by 1H and 19F NMR spectroscopy.
(B) Synthesis of the diazido curing agent:
The batch bismonoaddition of α,ω-diiodoperfluorohexane onto ethylene was performed in a 160 ml_ Hastelloy autoclave Parr System, equipped with a manometer, a rupture disk, inlet and outlet valves, and a mechanical anchor. An electronic device regulated and controlled both the stirring and the heating of the autoclave. The autoclave was left closed for 20 min. and purged with 30 bars of nitrogen pressure to prevent any leakage, and degassed afterwards. Then, a 2 mm Hg vacuum was operated for 15 min. The initiator di-4-tert-butylcyclohexyl peroxydicarbonate (4.22 g, 10 mmol) and 30.13 g (54.2 mmol) of 1-C6Fi2-I in dry tert-butanol (40 ml_) were introduced via a funnel tightly connected to the introduction valve. Next, ethylene (4.0 g, 0.14 mol) was introduced by double weighing. The autoclave was then heated up to 5O0C for 7 hours. After reaction, the autoclave was cooled to room temperature and then put into an ice bath. After degassing the unreacted monomer, the autoclave was opened. Tert-butanol was evaporated; the monomer was solubilized in THF and precipitated from cold pentane. The fluorinated diiodo product was filtered, washed, and dried at room temperature under a 20 mm Hg vacuum for 24 hours. The yield was 80%. FT-IR: 1138 cm'1 (VC-F)
α β g h i i h g β α ICH2CH2CF2CF2CF2CF2CF2CF2CH2CH2I
1H-NMR (δ CDCI3) α: 3.2 ppm (t, 3JHH=7.01 HZ, 4H); β: 2.6 ppm (m, 4H); 19F-NMR (δ CDCI3) g: -115.2 ppm (m, 4F); h: -121.8 ppm (m, 4F); i: -123.8 ppm (m, 4F).
A mixture composed of 7.80 g (12.8 mmol) of the above-prepared I .IO-diiodo-IH.I H^H^H.ΘH.ΘH.IOH.IOH-perfluorodecane and 2.21 g (30.8 mmol) sodium azide dissolved in DMSO (25 mL) and water (1 mL) was stirred at 500C for 48 hours. Then, the reaction mixture was poured into water and was extracted with diethyl ether. This procedure was repeated twice. The organic layer was washed with water twice, then with 10% sodium sulfite solution twice, water again (3 times) and then brine, dried over MgSO4 and filtered. Solvent was evaporated under reduced pressure to give 5.0 g of a pale green oil. The yield of the fluorinated diazide was 94%.
FT IR: 2100 crrT1 (vN3); 1138 cm 1 (VC-F) α β g h i i h g β α
N3CH2CH2CF2CF2CF2CF2CF2CF2CH2CH2N3
1H NMR (δ CDCI3) α: 3.55 ppm (t, 3JHH=7.07 HZ, 4H)1 β: 2.30 ppm (m, 4H) 19F NMR (δ CDCI3) g: -114.2 ppm (m. 4F); h: -121.8 ppm (m, 4F); i: -123.8 ppm (m, 4F)
A curable composition of the invention is made by dissolving 5 g of the above-prepared VF2/PMVE/8-CNVE fluoroelastomer in FC-75 solvent (available from 3M) and then mixed with 0.4 g of the telechelic 1 ,10- diazido-1H,1 H,2H,2H,9H,9H,10H,10H-perfluorodecane curing agent prepared above. This curable composition is mixed until a clear, transparent and homogenous solution is obtained. The curable composition is then cast into a mold, resulting in a film. The film is cured at 1500C for 14 to 20 hours.
Example 2
A curable composition of the invention was made by dissolving 5 g of a TFE/PMVE/8-CNVE fluoroelastomer (prepared substantially as disclosed in US Patent No. 5,789,489 and containing about 64-67 mol% TFE, 32-34 mol% PMVE and 0.7-1.2 mol% 8-CNVE) in FC-75 solvent (available from 3M) and then mixed with 0.4 g of the telechelic 1 ,10- diazido-I H.I H^H^H.ΘH.ΘH.IOH.IOH-perfluorodecane curing agent prepared above, and 0.5 g of zinc chloride. This curable composition was mixed until a clear, transparent and homogenous solution was obtained. The curable composition was then cast into a mold, resulting in a film. The film was cured at 1500C for 14 to 20 hours. The resulting crosslinked fluoroelastomer composition was insoluble in FC-75, whereas the uncured composition had been soluble in FC-75. TGA showed that T10% was 442°C, while it was 4240C for uncured fluoroelastomer.
A crosslinking mechanism is shown below wherein azide groups on the curative react with pendant nitrile groups on the fluoroelastomer to form crosslinks through tetrazole rings.
Figure imgf000015_0001

Claims

What is claimed is: 1. A curable composition comprising
A) a fluoroelastomer comprising copolymerized units of i) a first monomer selected from the group consisting of vinylidene fluoride and tetrafluoroethylene and ii) a cure site monomer having a cure site selected from the group consisting of azide, sulfonyl azide and carbonyl azide groups; and
B) a curative having the formula X-(CH2)n-R-(CH2)m-X, wherein X is an alkyne group or a nitrile group, n, m are independently 1 to 4, and R is selected from the group consisting of i) a C3 - C10 fluoroalkylene group, ii) a C3 - C10 fluoroalkoxylene group, iii) a substituted arylene group, iv) an oligomer comprising copolymerized units of vinylidene fluoride and perfluoro(methyl vinyl ether), v) an oligomer comprising copolymerized units of vinylidene fluoride and hexafluoropropylene, vi) an oligomer comprising copolymerized units of tetrafluoroethylene and perfluoro(methyl vinyl ether), and vii) an oligomer comprising copolymerized units of tetrafluoroethylene and a hydrocarbon olefin.
2. A curable composition of claim 1 wherein said cure site monomer is a sulfonyl azide selected from the group consisting of CF2=CFOCF2CF(CF3)OCF2CF2-SO2N3I CF2=CFOCF2CF2-SO2N3; CF2=CFOCF2CF2CF2-SO2N3; and CF2=CFOCF2CF2CF2CF2-SO2N3.
3. A curable composition of claim 1 wherein said cure site monomer is CF2=CFOCF2CF(CF3)OCF2CF2-CON3.
4. A curable composition of claim 1 wherein said fluoroelastomer further comprises copolymerized units of at least one additional monomer, different from said first monomer and said cure site monomer, wherein said additional monomer is selected from the group consisting of fluorine-containing olefins, fluorine-containing vinyl ethers and hydrocarbon olefins.
5. A curable composition of claim 4 wherein said additional monomer is a fluoroolefin selected from the group consisting of vinylidene fluoride; hexafluoropropylene; tetrafluoroethylene; 1 ,2,3,3, 3- pentafluoropropene; 1,1 ,3,3,3-pentafluoropropene; 3,3,3-trifluoropropene; chlorotrifluoroethylene and vinyl fluoride.
6. A curable composition of claim 4 wherein said additional monomer is a perfluoro(alkyl vinyl ether).
7. A curable composition of claim 1 wherein said curative is selected from the group consisting of NC-(CF2)n-CN and HC ≡C-(CF2)n-
C ≡CH wherein n is an integer between 2 and 20.
8. A curable composition comprising
A) a fluoroelastomer comprising copolymerized units of i) a first monomer selected from the group consisting of vinylidene fluoride and tetrafluoroethylene and ii) a cure site monomer having a cure site selected from the group consisting of nitrile groups, and alkyne groups; and
B) a curative having the formula N3(Y)p-(CH2)π-R-(CH2)m-(Y)pN3, wherein Y is SO1 SO2, CeH4, or CO, p is 0 or 1 , n, m are independently 1 to 4, and R is selected from the group consisting of i) a C3 - C10 fluoroalkylene group, ii) a C3 - C10 fluoroalkoxylene group, iii) a substituted arylene group, iv) an oligomer comprising copolymerized units of vinylidene fluoride and perfluoro(methyl vinyl ether), v) an oligomer comprising copolymerized units of vinylidene fluoride and hexafluoropropylene, vi) an oligomer comprising copolymerized units of tetrafluoroethylene and perfluoro(methyl vinyl ether), and vii) an oligomer comprising copolymerized units of tetrafluoroethylene and a hydrocarbon olefin
9. A curable composition of claim 8 wherein said cure site monomer contains at least one nitrile group.
10. A curable composition of claim 9 wherein said cure site monomer containing at least one nitrile group is selected from the group consisting of CF2=CF-O(CF2)n-CN wherein n = 2-12; CF2=CF-O[CF2-CF(CF3)-O]n-CF2-CF(CF3)-CN wherein n= 0-4;
CF2=CF-[OCF2CF(CFa)]X-O-(CF2)H-CN wherein x = 1-2, and n = 1-4; CF2=CF-O-(CF2)H-O-CF(CF3)CN where n = 2-4; and CF2=CFOCF2CF(CF3)OCF2CF2CN.
11. A curable composition of claim 8 wherein said cure site monomer contains at least one alkyne group.
12. A curable composition of claim 11 wherein said cure site monomer containing at least one alkyne group is selected from the group consisting of CF2=CFOCF2CF(CF3)OCF2CF2-C=CH; CF2=CFOCF2CF(CF3)OCF2CF2-COOCH2C^CH; and CF2=CFOCF2CF(CF3)OCF2CF2-CH2CH2-O-CH2C=CH.
13. A curable composition of claim 8 wherein said fluoroelastomer further comprises copolymerized units of at least one additional monomer, different from said first monomer and said cure site monomer, wherein said additional monomer is selected from the group consisting of fluorine-containing olefins, fluorine-containing vinyl ethers and hydrocarbon olefins.
14. A curable composition of claim 13 wherein said additional monomer is a fluoroolefin selected from the group consisting of vinylidene fluoride; hexafluoropropylene; tetrafluoroethylene; 1 ,2,3,3,3- pentafluoropropene; 1 ,1 ,3,3,3-pentafluoropropene; 3,3,3-trifluoropropene; chlorotrifluoroethylene and vinyl fluoride.
15. A curable composition of claim 13 wherein said additional monomer is a perfluoro(alkyl vinyl ether).
16. A curable composition of claim 8 wherein said curative is selected from the group consisting of
N3CH2CH2CF2CF2CF2CF2CF2CF2CH2CH2N3; N3-CH2CH2 -(CF2J4-CH2CH2 N3; N3-CO-CH2-(CFz)4-CH2-CO-N3; and N3C2H4-PoIy(VF2-CO-PMVE)- C2H4N3.
PCT/US2010/030677 2009-06-17 2010-04-12 Curable fluoroelastomer compositions WO2010147697A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2012516082A JP5607730B2 (en) 2009-06-17 2010-04-12 Curable fluoroelastomer composition
CN201080027107.5A CN102549065B (en) 2009-06-17 2010-04-12 Curable fluoroelastomer compositions
EP10789893.4A EP2443193B1 (en) 2009-06-17 2010-04-12 Curable fluoroelastomer compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/486,325 US8288482B2 (en) 2009-06-17 2009-06-17 Curable fluoroelastomer compositions
US12/486,325 2009-06-17

Publications (2)

Publication Number Publication Date
WO2010147697A2 true WO2010147697A2 (en) 2010-12-23
WO2010147697A3 WO2010147697A3 (en) 2011-03-31

Family

ID=43354894

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/030677 WO2010147697A2 (en) 2009-06-17 2010-04-12 Curable fluoroelastomer compositions

Country Status (5)

Country Link
US (2) US8288482B2 (en)
EP (1) EP2443193B1 (en)
JP (2) JP5607730B2 (en)
CN (1) CN102549065B (en)
WO (1) WO2010147697A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013087498A1 (en) 2011-12-16 2013-06-20 Solvay Specialty Polymers Italy S.P.A. Fluoroallylsulfonyl azide monomers and polymers there from
JP2015505885A (en) * 2011-12-16 2015-02-26 ソルベイ スペシャルティ ポリマーズ イタリー エス．ピー．エー． Crosslinkable composition based on vinylidene fluoride-trifluoroethylene polymer
WO2015077707A1 (en) * 2013-11-25 2015-05-28 E. I. Du Pont De Nemours And Company Curable fluoroelastomer composition
JP2015530475A (en) * 2012-10-02 2015-10-15 スリーエム イノベイティブ プロパティズ カンパニー Fluoropolyether-based elastomers with low glass transition temperature

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2499201B1 (en) * 2009-11-11 2017-05-10 3M Innovative Properties Company Polymeric compositions and method of making and articles thereof
US9862787B2 (en) 2011-12-12 2018-01-09 Solvay Specialty Polymers Italy S.P.A. Curable composition
RU2014129046A (en) 2011-12-16 2016-02-10 Солвей Спешиалти Полимерс Итали С.П.А. BINDABLE POLYMERS OF VINYLIDENFLUORIDE AND TRIFTORETHYLENE
WO2014052565A1 (en) * 2012-09-28 2014-04-03 E. I. Du Pont De Nemours And Company Perfluoroalkyl-crosslinked fluoropolymer with perfluoroether pendant groups
US20150225516A1 (en) * 2012-09-28 2015-08-13 E I Du Pont De Nemours And Company Crosslink stabilization process for azo-crosslinked fluoropolymer with perfluoroether pendant groups
JP2015532323A (en) * 2012-09-28 2015-11-09 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ Imageable articles comprising a substrate having an imageable crosslinkable fluoropolymer film disposed thereon, as well as imaging articles made therefrom
WO2014052539A2 (en) * 2012-09-28 2014-04-03 E. I. Du Pont De Nemours And Company Dichloroamino-functionalized fluoropolymer and process for preparing
US9481769B2 (en) * 2012-09-28 2016-11-01 E I Du Pont De Nemours And Company Direct crosslinking process for preparing perfluoroalkyl-cross-linked fluoropolymer having perfluoroether pendant groups
EP2989131B1 (en) 2013-04-22 2017-01-25 Solvay Specialty Polymers Italy S.p.A. Cross-linkable polymers comprising sulfonic acid functional groups
US20150148493A1 (en) * 2013-11-25 2015-05-28 E I Du Pont De Nemours And Company Curable fluoroelastomer composition
US10234121B2 (en) * 2015-01-05 2019-03-19 Cree, Inc. Flat trim ring lens for occupancy sensors
FR3038322B1 (en) * 2015-07-01 2018-10-19 Universite De Montpellier (Universite Montpellier 2 Sciences Et Techniques) LOW-THERMOSTABLE AND THERMOSTABLE THERMOSETTING CROSS-LINKABLE MATERIALS BASED ON FLUOROETHERS
JP6642580B2 (en) * 2015-09-01 2020-02-05 Ａｇｃ株式会社 Fluoropolymer, method for producing the same, and cured product of fluoropolymer
US10836893B2 (en) * 2015-12-07 2020-11-17 Dupont Polymers, Inc. Curing agents for compounds
JP7210440B2 (en) * 2016-10-27 2023-01-23 ソルベイ スペシャルティ ポリマーズ イタリー エス．ピー．エー． fluoroelastomer composition
WO2018159307A1 (en) * 2017-03-01 2018-09-07 Ａｇｃ株式会社 Fluoropolymer, method for producing cured product thereof, and light-emitting device
CN113166325B (en) * 2018-12-06 2024-02-27 索尔维特殊聚合物意大利有限公司 High heat rating fluoroelastomer compositions
US11492457B2 (en) * 2019-06-06 2022-11-08 3M Innovative Properties Company Curable fluoropolymer compositions comprising a compound containing a phthalonitrile and a nucleophilic functional group and cured articles therefrom
CN111499836B (en) * 2020-04-21 2022-03-04 临沂大学 Method for converting and utilizing perfluoroiodide, obtained product and application

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2515246A (en) 1946-06-30 1950-07-18 Purdue Research Foundation Polyfluoro aliphatic diamines
US4020176A (en) 1975-07-14 1977-04-26 Polaroid Corporation Highly fluorinated diazides and process therefor
JPS5657811A (en) 1979-10-17 1981-05-20 Daikin Ind Ltd Preparation of liquid fluorine-containing polymer
US4474700A (en) * 1981-07-02 1984-10-02 E. I. Du Pont DeNemours and Company β-Substituted polyfluoropropionate salts and derivatives
US5807937A (en) * 1995-11-15 1998-09-15 Carnegie Mellon University Processes based on atom (or group) transfer radical polymerization and novel (co) polymers having useful structures and properties
US5877264A (en) * 1996-11-25 1999-03-02 E. I. Du Pont De Nemours And Company Fast-curing perfluoroelastomer composition
US6114452A (en) * 1996-11-25 2000-09-05 E. I. Du Pont De Nemours And Company Perfluoroelastomer composition having excellent heat stability
US6365693B1 (en) * 1999-05-07 2002-04-02 Dupont Dow Elastomers, L.L.C. Fluoroalkanesulfonyl azide copolymers
US6844030B2 (en) * 2001-12-14 2005-01-18 3M Innovative Properties Company Process for modifying a polymeric surface
US8128393B2 (en) * 2006-12-04 2012-03-06 Liquidia Technologies, Inc. Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom
US8288492B2 (en) 2007-10-23 2012-10-16 E I Du Pont De Nemours And Company Difunctional oligomers of perfluoro(methyl vinyl ether)
CN102159641B (en) * 2008-07-31 2013-12-18 3M创新有限公司 Fluoropolymer compositions and method of making and using thereof
US8247614B2 (en) 2009-06-17 2012-08-21 E I Du Pont De Nemours And Company Copolycondensation polymerization of fluoropolymers

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of EP2443193A4 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013087498A1 (en) 2011-12-16 2013-06-20 Solvay Specialty Polymers Italy S.P.A. Fluoroallylsulfonyl azide monomers and polymers there from
US20140329970A1 (en) * 2011-12-16 2014-11-06 Solvay Specialty Polymers Italy S.P.A. Fluoroallylsulfonyl azide monomers and polymers there from
JP2015505885A (en) * 2011-12-16 2015-02-26 ソルベイ スペシャルティ ポリマーズ イタリー エス．ピー．エー． Crosslinkable composition based on vinylidene fluoride-trifluoroethylene polymer
JP2015505847A (en) * 2011-12-16 2015-02-26 ソルベイ スペシャルティ ポリマーズ イタリー エス．ピー．エー． Fluoroallylsulfonyl azide monomers and polymers therefrom
US10208147B2 (en) 2011-12-16 2019-02-19 Solvay Specialty Polymers Italy S.P.A. Fluoroallylsulfonyl azide monomers and polymers there from
JP2015530475A (en) * 2012-10-02 2015-10-15 スリーエム イノベイティブ プロパティズ カンパニー Fluoropolyether-based elastomers with low glass transition temperature
WO2015077707A1 (en) * 2013-11-25 2015-05-28 E. I. Du Pont De Nemours And Company Curable fluoroelastomer composition
US9611383B2 (en) 2013-11-25 2017-04-04 E I Du Pont De Nemours And Company Curable fluoroelastomer composition

Also Published As

Publication number Publication date
US20100324222A1 (en) 2010-12-23
EP2443193A2 (en) 2012-04-25
EP2443193B1 (en) 2014-02-12
JP5607730B2 (en) 2014-10-15
US8288482B2 (en) 2012-10-16
JP2014221919A (en) 2014-11-27
US8501872B2 (en) 2013-08-06
CN102549065B (en) 2014-07-30
CN102549065A (en) 2012-07-04
WO2010147697A3 (en) 2011-03-31
EP2443193A4 (en) 2013-01-16
JP2012530800A (en) 2012-12-06
US20130012673A1 (en) 2013-01-10

Similar Documents

Publication Publication Date Title
EP2443193B1 (en) Curable fluoroelastomer compositions
CA1225499A (en) Fluorinated copolymers with improved cure site components
US5554680A (en) Heat-resistant perfluoroelastomer composition
US5700879A (en) Fluorine-containing elastomer composition
US6221970B1 (en) Curable perfluoroelastomer composition
KR101853987B1 (en) Fluoroelastomer composition
JP3293630B2 (en) Iodine-containing chain transfer agents for fluoromonomer polymerization
EP1090050A1 (en) Thermally stable perfluoroelastomer composition
EP1587784B1 (en) Bisaminophenyl-based curatives and amidine-based curatives and cure accelerators for perfluoroelastomeric compositions
KR20070093083A (en) Fluoropolymers having pendant amidoxime or amidrazone structures
US20050171257A1 (en) Perfluoroelastomer composition for use in vulcanization and method for making a molded perfluoroelastomer product
JP2007517964A (en) Fluoroelastomer having improved low temperature characteristics and method for producing the same
KR102120657B1 (en) Peroxide-curable fluoropolymer composition including solvent and method of using the same
US8247614B2 (en) Copolycondensation polymerization of fluoropolymers
EP3239227B1 (en) Curing agents for compounds
JP6014157B2 (en) Curing composition for fluoropolymer
KR20190075975A (en) Fluoroelastomer composition
WO2015077700A1 (en) Curable fluoroelastomer composition

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080027107.5

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10789893

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2010789893

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2012516082

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE